Exkivity

mobocertinib · Takeda Pharma A/S

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Exkivity, covering 2022-11-24 to 2022-11-24. Get the full timeline:

Most recent: EMA Application withdrawn: Exkivity (mobocertinib) — Takeda Pharma A/S